Societal CDMO(REPH)
2.09 0.00 0.0%
| 今开：0.0 | 昨收：2.09 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.17926555E8 |
Societal CDMO的最新讨论
牛唐2019-03-18 17:34
$Recro制药(REPH)$ 的N1539治疗术后疼痛在去年吃了CRL，主要原因是数据及次要终点的选择不符合FDA的预期，这个月24号第二次申请，过的概率有，但不会很大查看全文
![[加]](http://js.xueqiu.com/ugc/images/face/emoji_52_plus.png?v=1 "[加]"){kind=small}
![[哭泣]](http://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
Societal CDMO的公告
$Recro Pharma(REPH)$ EFFECT - Notice of Effectiveness Filed: 2017-06-12 AccNo: 9999999995-17-001512 Size: 1 KB 网页链接
$Recro Pharma(REPH)$ 内部交易: 2017-06-08,Possible Member of 10% Group,Flynn James E ,卖出,17245普通股, $6.99
$Recro Pharma(REPH)$ 内部交易: 2017-06-07,Possible Member of 10% Group,Flynn James E ,卖出,45623普通股, $7.09
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2017-06-09 AccNo: 0001193125-17-199723 Size: 103 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial...
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2017-06-08 AccNo: 0001193125-17-197645 Size: 17 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-06-02 AccNo: 0001193125-17-193049 Size: 624 KB 网页链接
$Recro Pharma(REPH)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-05-19 AccNo: 0001105806-17-000014 Size: 5 KB 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2017-05-18 AccNo: 0001193125-17-175258 Size: 19 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2017-05-18 AccNo: 0001193125-17-174506 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-05-16 AccNo: 0000935836-17-000251 Size: 57 KB 网页链接